What is NDC 17856-1133?

17856-1133 is the product NDC for Spironolactone, Spironolactone 25 mg/5mL suspension, listed with the FDA by ATLANTIC BIOLOGICALS CORP.. It has 6 package NDCs, shown above in 10- and 11-digit form.

ATLANTIC BIOLOGICALS CORP., NDC labeler code 17856. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Spironolactone?

177 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Spironolactone NDC 17856-1133 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-1133Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-1133Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
17856-1133-1	1785611330117856113301	1 SYRINGE in 1 BAG (17856-1133-1) / 2.5 mL in 1 SYRINGE (17856-1133-3)Marketed from Jun 3, 2024
17856-1133-4	1785611330417856113304	1 SYRINGE in 1 BAG (17856-1133-4) / 2.5 mL in 1 SYRINGE (17856-1133-2)Marketed from Sep 26, 2025
17856-1133-5	1785611330517856113305	120 SYRINGE in 1 CASE (17856-1133-5) / 1 mL in 1 SYRINGEMarketed from Apr 30, 2026
17856-1133-6	1785611330617856113306	120 SYRINGE in 1 CASE (17856-1133-6) / 3 mL in 1 SYRINGEMarketed from Apr 30, 2026
17856-1133-7	1785611330717856113307	1 SYRINGE in 1 BAG (17856-1133-7) / 1 mL in 1 SYRINGEMarketed from Jul 2, 2026
17856-1133-8	1785611330817856113308	1 SYRINGE in 1 BAG (17856-1133-8) / 3 mL in 1 SYRINGEMarketed from Jul 2, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Spironolactone
Generic name (nonproprietary): spironolactone
Active ingredients: Spironolactone — 25 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: ATLANTIC BIOLOGICALS CORP.NDC labeler code 17856
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 209478
Marketing start: Oct 31, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Aldosterone Antagonists (Mechanism)
Identifiers: Product ID 17856-1133_59f7927f-899d-3af9-e063-6394a90aacbdSPL ID 59f7927f-899d-3af9-e063-6394a90aacbdSPL set ID 122558a0-57bb-4195-9adf-d37b049cbfb5RxCUI 104232UNII 27O7W4T232
Pharmacologic class: Aldosterone Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856113301 followed by a unit qualifier and the quantity

Package 17856-1133-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 26, 2026.

Indications (excerpt from the label)

Spironolactone oral suspension is an antagonist of aldosterone indicated for: the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure ( 1.1 ) use as an add-on therapy for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.2 ) the management of edema in adult cirrhotic patients when edema is not responsive to fluid and sodium restrictions ( 1.3 ) 1.1 Heart Failure Spironolactone oral suspension is indicated for treatment of NYHA Class II…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 17856-1133

What is NDC 17856-1133?: 17856-1133 is the product NDC for Spironolactone, Spironolactone 25 mg/5mL suspension, listed with the FDA by ATLANTIC BIOLOGICALS CORP.. It has 6 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Spironolactone.
What is the active ingredient?: Spironolactone.
Who is the labeler?: ATLANTIC BIOLOGICALS CORP., NDC labeler code 17856. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Spironolactone?: 177 other product NDCs are listed under this name. See all Spironolactone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Spironolactone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Spironolactone	Spironolactone 100 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-4188	68788-4188-0368788-4188-0668788-4188-09
Spironolactone	Spironolactone 50 mg/1	Tablet, CoatedOral	Coupler LLC	67046-0613	67046-0613-03
Spironolactone	Spironolactone 25 mg/1	Tablet, CoatedOral	Coupler LLC	67046-0744	67046-0744-03
Spironolactone	Spironolactone 25 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-087	48433-0087-20
Spironolactone	Spironolactone 50 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-088	48433-0088-20
Spironolactone	Spironolactone 100 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-089	48433-0089-08
Spironolactone	Spironolactone 100 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1636	67046-1636-03
spironolactone	Spironolactone 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4512	70518-4512-0070518-4512-02
Spironolactone	Spironolactone 25 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-706	64980-0706-0164980-0706-50
Spironolactone	Spironolactone 50 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-707	64980-0707-0164980-0707-50

All 178 Spironolactone NDCs

Other NDCs under NDA 209478

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 209478
Product	Strength	Form · route	Labeler	Product NDC
CaroSpir	Spironolactone 25 mg/5mL	SuspensionOral	CMP Pharma, Inc.	46287-020
Spironolactone	Spironolactone 25 mg/5mL	SuspensionOral	Padagis US LLC	0574-1133
Spironolactone	Spironolactone 25 mg/5mL	SuspensionOral	Atlantic Biologicals Corp.	17856-1233